Bristol-Myers Squibb
BMY
#181
Rank
NZ$206.92 B
Marketcap
NZ$101.33
Share price
1.73%
Change (1 day)
28.82%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.06. In 2025 the company made an earnings per share (EPS) of NZ$5.89 an increase over its 2024 EPS that were of NZ-$7.52.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.103.69%
2025NZ$5.89-178.28%
2024NZ-$7.52-213.92%
2023NZ$6.6030.2%
2022NZ$5.07-6.04%
2021NZ$5.40-179.29%
2020NZ-$6.81-281.37%
2019NZ$3.75-27.21%
2018NZ$5.16
2016NZ$4.54175.26%
2015NZ$1.65-19.83%
2014NZ$2.06-22.44%
2013NZ$2.6534.48%
2012NZ$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.87 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.95 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.50-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.03 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.64 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.36-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.91 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.05-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.83 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK